drugset / Trial / NCT02176291

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine

NCT02176291

RandomizedParallel-groupTriple-blindTreatment

Summary

The purposes of this project are to examine the feasibility, safety, tolerability and clinical effect of low-dose buprenorphine as a novel treatment for late-life treatment-resistant depression and to develop preliminary data about mechanism of action.

Timeline

Start
2014-08
Primary completion
2017-04
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 0.2 mg Other
Subject Buprenorphine Other / unclassified 2 mg Other